Insider Transactions last 24 months for Vanda Pharmaceuticals Inc.  -  NSDQ: VNDA

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Polymeropoulos Mihael HristosPresident and CEO08/07/2025APDirectCOM10,000$4.15$41,500.002,335,731
Mitchell Stephen RayDirector06/13/2025DSDirectCOM7,000$4.59$32,130.0097,082
Ward Anne SempowskiDirector06/05/2025AADirectCOM59,225$0.00$0.00119,067
Honore TageDirector06/05/2025AADirectCOM59,225$0.00$0.00123,469
Dugan Richard WDirector06/05/2025AADirectCOM59,225$0.00$0.00177,454
Chrousos PhaedraDirector06/05/2025AADirectCOM59,225$0.00$0.00123,350
Mitchell Stephen RayDirector06/05/2025AADirectCOM59,225$0.00$0.00104,082
Polymeropoulos Mihael HristosPresident and CEO05/21/2025APDirectCOM481$4.39$2,111.592,325,731
Polymeropoulos Mihael HristosPresident and CEO05/21/2025APDirectCOM9,519$4.40$41,883.602,325,250
Polymeropoulos Mihael HristosPresident and CEO05/16/2025APDirectCOM20,000$4.22$84,472.002,315,731
Polymeropoulos Mihael HristosPresident and CEO03/06/2025APDirectCOM5,000$5.01$25,050.002,295,731
Polymeropoulos Mihael HristosPresident and CEO03/06/2025APDirectCOM5,000$5.02$25,100.002,290,731
Polymeropoulos Mihael HristosPresident and CEO03/05/2025APDirectCOM5,000$5.03$25,150.002,285,731
Polymeropoulos Mihael HristosPresident and CEO03/05/2025APDirectCOM5,000$5.01$25,050.002,280,731
Polymeropoulos Mihael HristosPresident and CEO03/03/2025APDirectCOM10,000$4.71$47,050.002,275,731
Williams TimothySVP & General Counsel03/01/2025DFDirectCOM26,941$4.76$128,239.16294,884
Moran Kevin PatrickSVP, CFO & Treasurer03/01/2025DFDirectCOM26,941$4.76$128,239.16328,822
Polymeropoulos Mihael HristosPresident and CEO03/01/2025DFDirectCOM95,999$4.76$456,955.242,265,731
Birznieks GuntherSVP, Business Development03/01/2025DFDirectCOM26,941$4.76$128,239.16411,628
Wijkstrom JoakimSVP, Chief Marketing Officer03/01/2025DFDirectCOM15,520$4.76$73,875.20239,269
Polymeropoulos Mihael HristosPresident and CEO02/26/2025APDirectCOM5,000$4.78$23,900.002,341,730
Polymeropoulos Mihael HristosPresident and CEO02/26/2025APDirectCOM5,000$4.75$23,750.002,336,730
Polymeropoulos Mihael HristosPresident and CEO02/25/2025APDirectCOM10,000$4.46$44,640.002,331,730
Moran Kevin PatrickSVP, CFO & Treasurer02/21/2025APDirectCOM2,000$4.39$8,778.80355,763
Williams TimothySVP & General Counsel02/18/2025AADirectCOM125,000$0.00$0.00321,825
1   2  Next Last  You are at page 1 of 2 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel